Medical Disposables & Supplies Limited (MDS), a provider of medical and pharmaceutical products, has announced the appointment of Sheree Martin as an Independent Director and Chris Williams as its board mentor.
These appointments come as part of MDS’s strategic course of redirection, promising stability and growth for team members, business partners, and investors.
Sheree Martin joins the board, replacing Sandra Glasgow, who served the company with dedication and distinction for a decade. Martin brings a wealth of experience in strategic management, corporate governance, and business development. With a distinguished career spanning over two decades, she has held key leadership positions in various industries, driving transformative initiatives and fostering growth at some of the country’s leading institutions. Her expertise will be instrumental in guiding MDS on this new chapter.
Chris Williams, a seasoned executive with extensive experience in financial management and strategic planning, joins MDS as its board mentor. His proven track record of leading regional businesses through significant growth and change plus experience in governance will be an excellent asset to guiding MDS. Williams’ insights and strategic vision will support MDS’ efforts to enhance operational efficiency, expand market reach, and achieve long-term sustainability.
The input and impact of Sheree Martin and Chris Williams will be pivotal in achieving the strategic goals to take MDS to the next stage of growth. Their combined expertise and leadership will help steer MDS towards a future of stability and growth, benefiting team members, business partners, and investors alike.
“We are excited to welcome Sheree Martin and Chris Williams to the MDS family,” said Kurt Boothe, C.E.O. of Medical Disposables & Supplies Limited. “Their wealth of experience and strategic insights will be invaluable as we navigate this new phase of growth and development. We are confident that their contributions will help us achieve our short and long-term goals, ensuring a prosperous future for MDS.”
Comments